Quoting from NZ's post yesterday:
" From my own investment perspective , I'm here simply because.PAA a tiny Perth Based Biotech has a signed agreement with a Multinational Pharmaceutical fortune 500 company. Elanco / Eli Lilly.Elanco would not waste their time and resources on even talking with a bay biotech... But they saw value here and wanted to secure it early.. best type of due diligence carried out by a multinational that would have asked some hard questions to Roger Aston..I have not been able to locate another ASX Biotech with a Manufacture and Distribution agreement with a significant partner the size of Elanco,,PAA have had several meetings in Seattle with Elanco,, my opinion is so the Primary endpoints could be aligned with Elancos expectation "
Exactly right NZ.
The media link from NZ's post today that everyone should read:
https://www.businessnews.com.au/article/PharmAust-signs-cancer-drug-deal
And from me:
All I can say is hurry up PAA getting phase 2 off the ground ASAP !
Cheers
Ann: GMP Tablet Manufacture Commences for Canine Clinical Trials, page-12
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.015(6.98%) |
Mkt cap ! $82.69M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 23.0¢ | 21.5¢ | $475.3K | 2.128M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 93524 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 71004 | 2 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |
Day chart unavailable
